Wall Street PR

USN Using Plandai Biotechnology Inc (OTCMKTS:PLPL)’s Phytofare To Develop New Products (HBRM, MBLX)

Plandai Biotechnology Inc (OTCMKTS:PLPL) is pleased to announce that Ultimate Sports Nutrition (USN) is using its flagship product Phytofare for new developments. According to reports, Phytofare is one of the leading green tea catechin-based bioavailable complex that is used in tea products.

Tapping International Markets

USN intends to tap New Zealand and Australian markets with the help of Phytofare. As part of the agreement signed between these two companies, USN is bound to use Phytofare in all those products that are sold and manufactured in South Africa and Europe. With time, the competition in the market is on the rise, which has prompted both of them to take the existing relation to newer height.

Plandai has decided to allow its partner USN to distribute Phytofare through other manufacturers in its contact list in New Zealand and Australia market. With this initiative, USN and Plandai want to check if the existing relation between them is fruitful or not. According to Plandai’s President of marketing and sales, Callum Baylis-Duffield, it’s a privilege to have USN as distributing partner. So far it has done a great job in terms of selling Phytofare in different markets. USN was founded in 2000 in South Africa and has been a premium nutrition and health supplement brand since then.

Herborium Group, Inc. (OTCMKTS:HBRM) has decided to launch a few websites focusing on its flagship product named AcnEase. According to reports, it is capable of addressing issues like rosacea and acne through natural treatments. Herborium doesn’t want to leave any stone unturned when it comes to promoting AcnEase.  The current decision of launching different websites altogether is part of a bigger digital media plan that it seeks to roll out until the end of 2015.

Metabolix, Inc. (NASDAQ:MBLX) has announced financial results for 2Q2015 ending June 30. It managed to raise $15 million through private placement during the quarter, which helped it strengthening the balance sheet. Metabolix ended the quarter with $22.7 million in the form of cash and cash equivalents. Total loss of the company during the first six months of 2015 accounted for $11.9 million compared to last year’s $14.3 million.